2024 Australia–New Zealand Expert Consensus Statement on Cardiac Amyloidosis

Bart, Nicole K. and Fatkin, Diane and Gunton, James and Hare, James L. and Korczyk, Dariusz and Kwok, Fiona and Lam, Kaitlyn and Russell, David and Sidiqi, Hasib and Sutton, Tim and Gibbs, Simon D.J. and Mollee, Peter and Thomas, Liza (2024) 2024 Australia–New Zealand Expert Consensus Statement on Cardiac Amyloidosis. Heart, Lung and Circulation, 33 (4). pp.420-442. ISSN 14439506

Full text not available from this repository.
Link to published document: http://doi.org/10.1016/j.hlc.2023.11.027

Abstract

Over the past 5 years, early diagnosis of and new treatments for cardiac amyloidosis (CA) have emerged that hold promise for early intervention. These include non-invasive diagnostic tests and disease modifying therapies. Recently, CA has been one of the first types of cardiomyopathy to be treated with gene editing techniques. Although these therapies are not yet widely available to patients in Australia and New Zealand, this may change in the near future. Given the rapid pace with which this field is evolving, it is important to view these advances within the Australian and New Zealand context. This Consensus Statement aims to update the Australian and New Zealand general physician and cardiologist with regards to the diagnosis, investigations, and management of CA.

Item Type: Article
Subjects: R Medicine > R Medicine (General)
Depositing User: Repository Administrator
Date Deposited: 18 Dec 2024 00:18
Last Modified: 18 Dec 2024 00:18
URI: https://eprints.victorchang.edu.au/id/eprint/1544

Actions (login required)

View Item View Item